Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artios Pharma
Biotech
Artios Pharma widens clinical ambitions with $115M series D
The biotech will use the funds to extend its clinical ambitions for its pipeline of DNA-damage-response-inhibiting cancer prospects.
Zoey Becker
Nov 17, 2025 8:00am
Pfizer vet lands first CEO role—Chutes & Ladders
Aug 15, 2025 8:30am
Merck KGaA steps up VC activity with $677M for M Ventures
Dec 8, 2021 8:00am
Artios raises $153M to fund DNA damage repair clinical trials
Jul 27, 2021 7:40am
Combating BRCA-mutated tumors via a new pathway
Jun 17, 2021 11:00am
Novartis taps Artios for targets to enhance radioligand drugs
Apr 7, 2021 2:00am
